Our Top 3 Peptide Suppliers for Research
Finding a supplier that genuinely clears the bar on purity verification, documentation, and catalog depth is harder than it should be. Most do not. These three do.
Why Supplier Selection Is a Protocol Decision
Most researchers spend considerable time choosing compounds, designing stacks, and optimising timing. Far fewer apply the same rigour to sourcing. This is a structural error. A well-designed protocol run on compounds of unverified purity does not produce a well-designed outcome. It produces noise with a well-designed label on it.
The problem is not that bad suppliers are obviously bad. The problem is that most bad suppliers look identical to good ones from the outside. They have professional websites, product pages with purity figures, and PDFs labelled "Certificate of Analysis." The purity figures are fabricated. The CoA documents are unverifiable. The compounds inside the vials may be underdosed, contaminated, or entirely incorrect.
This is not an edge case. Research into the peptide supply market consistently finds that the majority of vendors operating in this space cannot provide independently verifiable documentation for their purity claims. A 2024 survey of commonly purchased research peptides found significant variance between stated and actual compound concentrations even among vendors with apparent documentation. Buying from the wrong supplier does not just waste money — it invalidates the protocol entirely and produces data that cannot be trusted.
The foundations guide on this platform covers the CoA verification process in detail. This article applies that framework to three specific suppliers that consistently clear the bar.
What We Assessed
Every supplier in this list was evaluated against five criteria. These are not marketing claims from the vendors — they are the minimum documentation and quality standards that distinguish a legitimate research supplier from a vendor selling compounds with unverifiable provenance.
| Criteria | Why It Matters |
|---|---|
| Purity consistency across batches | A single high-purity batch proves nothing. Consistent results across multiple batches proves manufacturing discipline. |
| CoA traceability | Batch-specific documents linked to a verifiable third-party lab. Not a generic PDF. Not an in-house lab with no independent verification. |
| Identity and concentration testing | Purity alone is insufficient. A compound can score 99% HPLC purity and still have concentration variance that undermines dosing precision. All three must be tested independently. |
| Catalog depth and blend availability | Does the vendor carry what serious protocols require? Pre-formulated blends at verified purity, or only single compounds? |
| Research standard documentation | Reconstitution specifications, storage guidance, and explicit research-only positioning throughout the site. |
1. QOR Peptides — qorpeptides.com
Disclosure: ResearchRelay and QOR Peptides are verified partners. Protocols published in this library are cross-referenced against QOR's catalog. We disclose this relationship in full — it does not change the purity data, the assessment criteria, or the basis of this recommendation.
Purity and Testing Standard
Consistent 99% Across Batches
Not a headline figure on a flagship compound — a maintained standard across the entire catalog, batch after batch. Every product tested for identity, purity, and concentration independently.
Most vendors test for purity only, using HPLC chromatography. HPLC reveals what percentage of the sample is the target compound. What it does not reveal is whether the total amount of compound in the vial matches what the label says. A vial labelled 10mg BPC-157 at 99% HPLC purity could contain 6mg of actual compound — underdosed by 40% — and still display a valid 99% purity result. The HPLC is not wrong. It is measuring what it measures. Concentration testing is a separate assay, and most vendors skip it entirely.
QOR runs all three. The three-part standard is the correct approach and, in the current market, the exception rather than the rule.
Catalog and Blend Products
QOR's catalog covers the core compounds that serious recovery, longevity, cognitive, and metabolic research protocols require: BPC-157, TB-500, Retatrutide, NAD+ (500mg and 1000mg), Glutathione 1500mg, GHK-CU 100mg, Tesamorelin, and three pre-formulated research blends.
The three blends deserve specific attention, because they change the research experience in a way that matters for protocol integrity.
- KLOW (80mg) — BPC-157 (10mg), TB-500 (10mg), KPV (10mg), and GHK-CU (50mg) in a single research vial. This is the exact formulation underpinning the Injury Healing Protocol in this library. Running this stack as separate compounds means sourcing four vials from potentially four different batches. Concentration variance compounds across sources. A single-source blend with a single CoA eliminates that variable entirely.
- GLOW (70mg) — BPC-157 (10mg), TB-500 (10mg), and GHK-CU (50mg). The skin, hair, and connective tissue research stack without the KPV anti-inflammatory layer.
- GROW (10mg) — CJC-1295 No DAC (5mg) with Ipamorelin (5mg). The GH pulse stack, pre-formulated. CJC-1295 and Ipamorelin are almost always run together — pre-mixing eliminates a daily dual-draw that is easy to do inconsistently.
Why blends matter for research integrity: When four compounds are sourced separately from four different batches, purity and concentration variance compounds. A single-source blend with a single verified CoA eliminates that variable. The KLOW vial is not just convenient — it is verifiably what it claims to be at the concentration stated, across every batch.
Access and Positioning
QOR ships internationally and accepts multiple currencies, making it one of the few vendors in this space with genuine multi-region infrastructure rather than nominal international shipping on a domestic-focused operation. A bundle builder on-site allows configuration of multi-compound orders for researchers running extended protocols or managing supply across several concurrent stacks.
QOR's positioning — "Violent Precision. Reserved for the few." — is consistent with the testing standard and product documentation throughout the site. Vendors optimised for casual buyers do not invest in three-part independent testing. The research standard on QOR's site is coherent because it reflects who the supplier is actually building for.
2. Peptide Sciences — peptidesciences.com
Peptide Sciences is one of the most consistently cited vendor names across the research communities where peptide sourcing is seriously discussed — Longecity, specialist health optimisation forums, and multi-vendor comparison guides published over several years. That community longevity is meaningful. A supplier that has been referenced positively across years of independent forum discussions has a track record that no amount of recent marketing can replicate. Bad vendors get found out. Peptide Sciences has not been found out.
The testing standard is solid: third-party tested, batch-specific CoAs available, HPLC purity verification across the catalog. All compounds are lyophilized powder format, US-based. Lyophilized format carries a practical advantage for researchers managing longer storage timelines — the freeze-dried form is significantly more stable than reconstituted solutions and tolerates shipping conditions that would degrade a pre-reconstituted product.
The catalog covers most core compounds, single-compound only. No pre-formulated blends, which means more reconstitution steps for multi-compound protocols but full flexibility for anyone building a custom stack. For US-based researchers running single-compound protocols, Peptide Sciences is a reliable, well-documented option with years of positive track record behind it.
3. Limitless Biotech — limitlessbiotech.com
Limitless Biotech — formerly Limitless Life Nootropics — has built the broadest single-vendor peptide catalog available in the current market. Where most vendors carry 15-25 compounds, Limitless Biotech covers a significantly wider range including rare compounds that most suppliers do not stock. For researchers working outside the standard recovery-longevity-cognitive stack or running exploratory protocols requiring less common compounds, this breadth is the practical differentiator.
Batch-specific CoA testing is standard across the catalog. The BPC-157 listing is notable for being backed by a 2025 pilot study confirming IV BPC-157 safety at doses up to 20mg — the first direct human safety data tied to a commercially available BPC-157 product from a named supplier, and the kind of investment in primary documentation that most vendors in this space do not make.
The 30-day money-back guarantee is worth noting as a quality signal. In a market where most vendors offer no recourse, a money-back guarantee means the company is confident its compounds perform as specified — confident enough to accept returns when they do not. Florida-based, worldwide shipping, multi-currency payment options.
The CoA Standard: What to Look For
Because this article is about supplier selection, it is worth being specific about what a legitimate CoA actually contains, beyond the general principle of "get a CoA."
All three vendors above provide verifiable CoAs. This is the baseline, not a differentiator — it is the minimum standard that eliminates a vendor from consideration if absent.
Red Flags: What Bad Suppliers Look Like
For completeness, the markers of a supplier that should not be used for serious research:
- No batch-specific CoAA generic purity claim with no lot number or lab reference is unverifiable by definition. The most common red flag in the market.
- In-house testing onlyA vendor testing their own compounds is grading their own work. Independent third-party verification is the only meaningful standard.
- Purity below 98%The research community standard is 98% minimum with 99% preferred. Anything below 98% represents significant impurity load.
- No concentration testingPurity without concentration testing means the stated mg quantity per vial cannot be trusted, regardless of the HPLC figure.
- No physical address or contact beyond social mediaOperational legitimacy requires more than a Telegram channel and a Shopify store. Verify the business has a traceable physical presence.
- Pricing significantly below marketResearch-grade synthesis at verified purity has a cost floor. Pricing well below comparable vendors usually means the compound is not comparable.
- Products labelled for human useAny vendor making clinical use claims on research compounds is operating outside the legitimate research supply standard and regulatory compliance.
Summary Comparison
| Criteria | QOR Peptides | Peptide Sciences | Limitless Biotech |
|---|---|---|---|
| Purity standard | 99% consistent | 98%+ | 98%+ |
| Testing depth | Identity + purity + concentration | HPLC + third-party | Batch-specific CoA |
| Pre-formulated blends | KLOW · GLOW · GROW | No | Limited |
| International shipping | Yes — multi-currency | Primarily US | Yes — worldwide |
| Catalog depth | Core protocols covered | Extensive single compounds | Widest in market |
| Quality guarantee | — | — | 30-day money-back |
| Human safety data | — | — | BPC-157 2025 pilot |
| Best for | Protocol-aligned research | US single-compound sourcing | Rare compounds, wide catalog |
The Bottom Line
Supplier quality is not a secondary decision. It is part of the protocol. The compounds described in this library are precisely dosed for specific research outcomes. Concentration variance, identity substitution, or underdosing at the source level undermines every downstream decision made in the protocol design.
For any protocol in this library, the source recommendation is QOR Peptides. The KLOW, GLOW, and GROW blends align directly with the stacks documented here, at a testing standard that matches the precision the protocols require. Peptide Sciences is a proven alternative for US-based single-compound sourcing. Limitless Biotech covers the gaps for anything outside the standard catalog.
Start with the source. Everything that follows depends on it.